Details.
Private specialist Xolair, also known as omalizumab, treatment for confirmed IgE-mediated food allergies, including peanut, tree nut, egg, milk, wheat, sesame and shellfish allergies. Suitable for adults and children aged 1 to 65 years, particularly those with severe reactions, multiple food allergies or significant quality of life impacts. Includes comprehensive assessment, allergy testing, reaction history review, personalised dosing based on age, weight and IgE levels, subcutaneous injections every 2 to 4 weeks, safety monitoring and ongoing treatment response evaluation. The first treatment requires observation for up to 2 hours, with subsequent appointments generally requiring 30 minutes of observation. Allergen avoidance and emergency medication remain essential during treatment.